University of Minnesota-Pharmaceuticals & Healthcare-Deals and Alliances Profile

University of Minnesota-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH51765D
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

University of Minnesota (UM) is an educational institute that offers research, education and outreach services. The institute offers educational programs in the areas of medicine, social sciences, science and business. It offers under graduate degree, post graduate, masters and research courses. UM's schools and colleges offers courses in the areas of allied health programs, biological sciences, continuing education, dentistry, design, education and human development, extension, food, and agricultural and natural resource sciences. The institute operates research centers which include horticultural research center, excelsior, Itasca biological station and laboratories, large lakes observatory, mid-central research and outreach center, Minnesota landscape arboretum and natural resources research institute. UM is headquartered in Minneapolis, Minnesota, the US.

University of Minnesota-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

University of Minnesota, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

University of Minnesota, Medical Devices Deals, 2011 to YTD 2017 10

University of Minnesota, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

University of Minnesota, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Oxis International Enters into Research Agreement with University of Minnesota 13

Oxis International Enters into Research Agreement with University of Minnesota 13

Biocept Enters into Research Agreement with University of Minnesota 14

Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement 15

Targazyme Enters into Agreement with University of Minnesota Medical Center 16

Fate Therapeutics Enters into Research Agreement with Regents of the University of Minnesota 16

Licensing Agreements 17

Oxis Biotech Enters into Licensing Agreement with University of Minnesota 17

PlasmaTech Biopharma Enters into Licensing Agreement with University of Minnesota 18

Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 19

Apogen Biotech Enters into Licensing Agreement with University of Minnesota 20

RedHill Biopharma Enters into Licensing Agreement with University of Minnesota 20

Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 21

Minneamrita Therapeutics Enters into Licensing Agreement with University of Minnesota 22

University Of Minnesota Enters Into Licensing Agreement With Vytacera Pharma 23

Ariel Pharma Enters Into Licensing Agreement With University of Minnesota For Tamiasyn 24

Horizon Discovery Enters Into Licensing Agreement With University Of Minnesota 24

University Of Minnesota Enters Into Licensing Agreement With Flagship Biosciences 25

Horizon Discovery Enters Into Licensing Agreement With The University of Minnesota 26

Cellectis Enters Into Licensing Agreement With University Of Minnesota 27

University of Minnesota-Key Competitors 29

Key Employees 30

Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 33

Government and Public Interest 33

May 09, 2017: Delta-Opioid Agonists Can Attenuate Cardiac Injury 33

Dec 19, 2016: UMN researchers provide molecular portraits of a new cancer drug target 34

Sep 07, 2016: UNC and Minnesota researchers earn NIH grant to explore infant brain development 35

Feb 02, 2016: UMN study identifies mechanism for drug target to help block HIV's ability to spread 37

Product News 38

Oct 20, 2016: Optimal treatment plan for chronic myeloid leukemia suggested by mathematical modeling 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Figures

University of Minnesota, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

University of Minnesota, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

University of Minnesota, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

University of Minnesota, Pharmaceuticals & Healthcare, Key Facts 1

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

University of Minnesota, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

University of Minnesota, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

University of Minnesota, Deals By Therapy Area, 2011 to YTD 2017 9

University of Minnesota, Medical Devices Deals, 2011 to YTD 2017 10

University of Minnesota, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Oxis International Enters into Research Agreement with University of Minnesota 13

Oxis International Enters into Research Agreement with University of Minnesota 13

Biocept Enters into Research Agreement with University of Minnesota 14

Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement 15

Targazyme Enters into Agreement with University of Minnesota Medical Center 16

Fate Therapeutics Enters into Research Agreement with Regents of the University of Minnesota 16

Oxis Biotech Enters into Licensing Agreement with University of Minnesota 17

PlasmaTech Biopharma Enters into Licensing Agreement with University of Minnesota 18

Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 19

Apogen Biotech Enters into Licensing Agreement with University of Minnesota 20

RedHill Biopharma Enters into Licensing Agreement with University of Minnesota 20

Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 21

Minneamrita Therapeutics Enters into Licensing Agreement with University of Minnesota 22

University Of Minnesota Enters Into Licensing Agreement With Vytacera Pharma 23

Ariel Pharma Enters Into Licensing Agreement With University of Minnesota For Tamiasyn 24

Horizon Discovery Enters Into Licensing Agreement With University Of Minnesota 24

University Of Minnesota Enters Into Licensing Agreement With Flagship Biosciences 25

Horizon Discovery Enters Into Licensing Agreement With The University of Minnesota 26

Cellectis Enters Into Licensing Agreement With University Of Minnesota 27

University of Minnesota, Key Competitors 29

University of Minnesota, Key Employees 30

University of Minnesota, Other Locations 31

University of Minnesota, Subsidiaries 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

University of Minnesota, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16065
Site License
USD 500 INR 32130
Corporate User License
USD 750 INR 48195

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com